Extraosseous calcification. Evidence for abnormal pyrophosphate metabolism in uremia.
Open Access
- 1 March 1976
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 57 (3) , 692-699
- https://doi.org/10.1172/jci108326
Abstract
The inorganic constituents and crystalline features of extraosseous calcium-phosphate deposits obtained from dialyzed uremic and hypercalcemic patients were studied. Visceral calcification (heart, lung, and kidney) in hypercalcemic patients exhibited either an amorphous or apatitic X-ray diffraction pattern. Uremic visceral calcification consistently gave an amorphous diffraction pattern. Although the calcium content of uremic and hypercalcemic visceral deposits was similar, other inorganic constituents were different. The mean pyrophosphate was 11 +/- 11.8 and magnesium 4.91 +/- 3.86 mg/g in the uremic group as compared to 0.92 +/- 0.24 and 1.36 +/- 1.26 mg/g in the hypercalcemic group (P less than 0.025). After incineration hypercalcemic visceral deposits having an amorphous diffraction pattern were found to generate pyrophosphate supporting the presence of brushite in these deposits. The small amount of pyrophosphate in apatitic deposits from both uremic and hypercalcemic patients actually decreased after incineration and the pyrophosphate content of uremic visceral deposits was unchanged by incineration. It is concluded that in hypercalcemic patients the initial visceral deposit is brushite which is subsequently transformed to apatite. Arterial and tumoral calcium-phosphate deposits in uremic patients were also apatite. Uremic visceral calcium-phosphate deposits are an unique mineral high in magnesium with approximately 30% of the phosphorus present as pyrophosphate. The high pyrophosphate content of these deposits could alter their crystalline structure and prevent the transformation to apatite. The infrared features, high magnesium content of the deposit, and resistance of pyrophosphate in the deposit to hydrolysis by pyrophosphatase suggests that the pyrophosphate may be deposited as the magnesium salt.This publication has 19 references indexed in Scilit:
- Pulmonary Calcification in Chronic Dialysis PatientsAnnals of Internal Medicine, 1975
- Increased Inorganic Serum Pyrophosphate in Serum and Urine of Patients with Osteogenesis ImperfectaClinical Chemistry, 1975
- Cardiac calcification in uremia: A clinical, biochemical and pathologic studyThe American Journal of Medicine, 1971
- Potentiation of metastatic calcification in vitamin D-treated rats by magnesiumAmerican Journal of Physiology-Legacy Content, 1971
- Determination of orthophosphate in the presence of inorganic pyrophosphate in the assay of inorganic pyrophosphatase activityAnalytical Biochemistry, 1970
- The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphatesCalcified Tissue International, 1969
- Pyrophosphate and Diphosphonates in Calcium Metabolism and Their Possible Role in Renal FailureArchives of internal medicine (1960), 1969
- Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy.1969
- Intractable Pruritus as a Manifestation of Secondary Hyperparathyroidism in UremiaNew England Journal of Medicine, 1968
- Recurrent acute (?gouty) arthritis in chronic renal failure treated with periodic hemodialysisThe American Journal of Medicine, 1964